Status:
COMPLETED
Efficacy of Intermediate and High Intensity Regimens in Patients With Relapsed Acute Lymphoblastic Leukemia
Lead Sponsor:
Christian Omar Ramos-Peñafiel, MD, PhD
Conditions:
Acute Lymphoblastic Leukemia
Eligibility:
All Genders
15-60 years
Brief Summary
The aim of this study is to describe the survival and relapses of patients with diagnosis of acute lymphoblastic leukemia at two tertiary level hospitals in the metropolitan area of the valley of Mexi...
Detailed Description
Retrospective, observational study in patients with diagnosis of acute lymphoblastic leukemia, according to the criteria of the World Health Organization, from July, 2016, to October, 2020. The patien...
Eligibility Criteria
Inclusion
- Patients with diagnosis of acute lymphoblastic leukemia according to the criteria of the World Health Organization.
Exclusion
- Age less than 15 years
- Age over 60 years
Key Trial Info
Start Date :
July 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04699162
Start Date
July 1 2016
End Date
December 31 2020
Last Update
January 14 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Regional de Alta Especialidad de Ixtapaluca
Ixtapaluca, State of Mexico, Mexico, 56530
2
Hospital General de México "Dr. Eduardo Liceaga"
Mexico City, Mexico, 06720